US Stock MarketDetailed Quotes
TCBP TC BioPharm
- 0.6200
- -0.0300-4.62%
Trading Dec 19 09:56 ET
5.09MMarket Cap0.00P/E (TTM)
0.6900High0.6000Low941.24KVolume0.6900Open0.6500Pre Close604.47KTurnover11.47%Turnover Ratio0.00P/E (Static)8.21MShares41.500052wk High2.02P/B5.09MFloat Cap0.435952wk Low--Dividend TTM8.21MShs Float35000.0000Historical High--Div YieldTTM13.85%Amplitude0.4350Historical Low0.6420Avg Price1Lot Size
TC BioPharm Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 94.30%3.84M | 0.00%1.98M | 494.67K | 494.66K | -42.26%1.98M |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | 94.30%3.84M | 0.00%1.98M | --494.67K | --494.66K | -42.26%1.98M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -42.88%2.05M | -17.38%3.44M | -10.60%14.24M | 3.6M | 4.17M | 72.03%15.93M | 11.32%9.26M | 2.82M | 2.65M | -17.38%8.32M |
| Selling and administrative expenses | -25.35%1.12M | -3.98%2.14M | -22.41%6.47M | --1.49M | --2.23M | 168.14%8.34M | 40.88%3.11M | --1.18M | --1.05M | -26.80%2.21M |
| -General and administrative expense | -25.35%1.12M | -3.98%2.14M | -22.41%6.47M | --1.49M | --2.23M | 168.14%8.34M | 40.88%3.11M | --1.18M | --1.05M | -26.80%2.21M |
| Research and development costs | -55.34%939.29K | -32.85%1.3M | 2.36%7.77M | --2.1M | --1.93M | 23.32%7.59M | -7.83%6.16M | --1.65M | --1.6M | -22.45%6.68M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | 98.88%-6.38K | ---435 | --0 | 63.54%-569.2K |
| Operating profit | 42.88%-2.05M | 17.38%-3.44M | -17.84%-14.24M | -3.6M | -4.17M | -65.97%-12.08M | -14.86%-7.28M | -2.33M | -2.16M | 4.54%-6.34M |
| Net non-operating interest income expense | 98.77%-83.03K | -96.40%-6.75M | -1,081.49%-3.44M | -1.92M | -1.15M | -14.80%-291.03K | ||||
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | -96.79%33 | --5 | --7 | -95.30%1.03K |
| Non-operating interest expense | ---- | ---- | -98.77%83.03K | ---- | ---- | 96.40%6.75M | 1,077.33%3.44M | --1.92M | --1.15M | 6.05%292.06K |
| Other net income (expense) | -100.88%-37.59K | -99.71%9.06K | -53.64%7.33M | 4.29M | 3.13M | 470.60%15.8M | -4.26M | -271.35K | ||
| Gain on sale of security | --0 | -99.64%11.45K | -50.00%7.97M | --5.07M | --3.15M | 473.89%15.94M | ---4.26M | ---271.35K | ---- | ---- |
| Special income (charges) | 100.38%2.39K | 86.59%-2.39K | -360.19%-645.85K | ---628.05K | ---17.79K | ---140.34K | --0 | ---- | ---- | --0 |
| -Less:Other special charges | ---- | -86.59%2.39K | 360.19%645.85K | --628.05K | --17.79K | --140.34K | ---- | ---- | ---- | ---- |
| Income before tax | -401.97%-2.09M | -231.68%-3.43M | -130.61%-7M | 692.89K | -1.03M | 79.75%-3.03M | -126.00%-14.98M | -4.52M | -7.3M | 3.83%-6.63M |
| Income tax | 64.74%-105.79K | 72.31%-110.74K | 36.70%-1.09M | -300K | -400K | -22.20%-1.72M | -20.10%-1.41M | -620.09K | -274.94K | -41.87%-1.17M |
| Net income | -300.08%-1.99M | -423.20%-3.32M | -349.68%-5.91M | 992.89K | -634.91K | 90.32%-1.31M | -148.74%-13.58M | -3.9M | -7.03M | 10.05%-5.46M |
| Net income continuous Operations | -300.08%-1.99M | -423.20%-3.32M | -349.68%-5.91M | --992.89K | ---634.91K | 90.32%-1.31M | -148.74%-13.58M | ---3.9M | ---7.03M | 10.05%-5.46M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -300.08%-1.99M | -423.20%-3.32M | -349.68%-5.91M | 992.89K | -634.91K | 90.32%-1.31M | -148.74%-13.58M | -3.9M | -7.03M | 10.05%-5.46M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -300.08%-1.99M | -423.20%-3.32M | -349.68%-5.91M | 992.89K | -634.91K | 90.32%-1.31M | -148.74%-13.58M | -3.9M | -7.03M | 10.05%-5.46M |
| Basic earnings per share | -113.34%-4.0172 | 64.52%-22 | 49.74%-192 | 30.1139 | -62 | 94.50%-382 | -256.99%-6.94K | -1.99K | -3.59K | 10.05%-1.95K |
| Diluted earnings per share | -113.34%-4.0172 | 64.52%-22 | 49.74%-192 | 30.1139 | -62 | 94.50%-382 | -256.99%-6.94K | -1.99K | -3.59K | 10.05%-1.95K |
| Dividend per share | ||||||||||
| Currency Unit | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
